Hindustan Oil Exploration Company Limited — Others, 30-05-2025: Copy of Newspaper Publication
Hindustan Oil Exploration Company Limited has announced a board meeting to consider the financial results for the quarter and half-year. ECL Finance Limited took physical possession of commercial properties in Mehsana after Dahlia Traders Pvt Ltd defaulted on dues totaling Rs. 1.72 Cr plus Rs. 2.26 lakh, reinforcing ECL’s recovery measures. Glenmark Pharmaceuticals is advancing a licensing deal for its FDA fast-tracked cancer drug ISB 2001 while preparing to launch semaglutide in India, shifting clinical supply manufacturing from Switzerland to global partners to meet demand. Arvind plans a ₹475 Cr capex for FY26 to increase garment capacity, targeting growth from the India-UK FTA and reducing US market reliance. Mapmygenome acquired Canadian Microbiome Insights to expand into the US with enhanced microbiome testing capabilities using AI-driven genomics.
All announcements from Hindustan Oil Exploration Company Limited
